News & Press Releases Swedish

TSE-behandlingar vid Royal Veterinary College visar mycket lovande resultat

Scandinavian ChemoTechs helägda dotterbolag Vetiqure får mycket lovande uppdateringar från veterinärerna på Royal Veterinary College (RVC) som nu kommer att behandla fler patienter med ChemoTechs tumörspecifika elektroporationsteknik (TSE).

Read more

TSE-behandlingar utfördes på tre hästar utan generell anestesi vid Royal Veterinary College i London

Scandinavian ChemoTechs Animal Care-division, Vetiqure, har framgångsrikt genomfört utbildning av personal vid Royal Veterinary College (RVC) Equine, som efteråt utförde tre mycket lovande TSE-behandlingar (Tumörspecifik Elektroporation) utan narkos. De tre behandlade hästarna led av melanom och sarkoider på olika platser. Alla hästar kunde framgångsrikt behandlas under lugnande medel i kombination med lokalbedövning och/eller nervblockad, vilket…

Read more

–

Read all news in Swedish

News & Press Releases English

TSE treatments at the Royal Veterinary College shows very promising results

Scandinavian ChemoTech’s fully owned subsidiary Vetiqure receives very promising updates from the veterinarians at the Royal Veterinary College (RVC), who will now continue to treat more patients.

Read more

TSE treatments were performed on three horses without general anaesthesia at the Royal Veterinary College in London

Scandinavian ChemoTech’s Animal Care division, Vetiqure, has successfully conducted training of staff at Royal Veterinary College (RVC) Equine, who afterwards performed three very promising TSE (Tumour Specific Electroporation) treatments without general anaesthesia. The three horses treated were suffering from melanomas and sarcoids situated in various locations. All horses could successfully be treated under sedation in…

Read more

–

Read all news in English

Various information

Reportage in the magazine Ridsport regarding our
TSE technology

Link to - Reportage in the magazine Ridsport

Meet our product specialist Elin!

Are you interested in our product? Then please contact us on info@vetiqure.se to book an appointment.

Poster presented at ESVONC 2022

Treatment of equine sarcoids using intratumoral Bleomycin in combination with Tumour Specific Electroporation - TSE™, Majbritt M E Larsen, Philip Kieffer

Our foundation

Our profound knowledge in electroporation forms the starting point for the company’s existing product vetIQure™, specially desinged for TSE – Tumour Specific Electroporation – treating a range of different types of tumours in pets.
READ MORE

Our research focus

vetIQure™ is a new innovation in cancer care based on the patented technology Tumour Specific Electroporation (TSE) designed for safe and easy cancer treatment of animals. Our aim is to document the effects of elctrochemotherapy within an area with significant unmet medical need.
READ MORE